C/A 0002066836 XXXXXXXX 020-36215 LIVE false false false false Correction to the Target Number of Securities to be Offered in the Offering Information on Part I of Form C Conexeu Sciences Inc. Corporation NV 11-02-2022 50 WEST LIBERTY STREET, SUITE 880 RENO NV 89501 http://www.conexeu.com/ N Equifund Crowd Funding Portal Inc. 0001705665 007-00115 000288900 The Intermediary will receive a commission equal to seven and one half percent (7.5%) of the amount raised in the offering. The Intermediary will receive a number of shares of common stock of the issuer that is equal to two percent (2%) of the total number of shares of common stock sold by the issuer in the offering. Common Stock 10000 2.00000 per share 20000.00 Y Other At the Company's discretion 5000000.00 04-29-2026 0.00 533940.00 0.00 314616.00 0.00 0.00 0.00 7912.00 4275.00 98117.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -471867.00 -35697.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Conexeu Sciences Inc. /s/ Jeff Sharpe Chief Executive Officer and Director /s/ Jeff Sharpe Chief Executive Officer and Director 07-30-2025 /s/ Stephen Inouye Chief Financial Officer, Secretary, Treasurer 07-30-2025 /s/ Brian Pilcher President, Chief Medical Officer and Director 07-30-2025